Phase 2/3 multi-center, double-blind, controlled trial comparing topical ARYS-01 (sorivudine) cream 3 percent, oral valaciclovir, and combination topical ARYS-01 cream /oral valaciclovir for treatment of herpes zoster in immunocompetent patients 18 years of age or older

Trial Profile

Phase 2/3 multi-center, double-blind, controlled trial comparing topical ARYS-01 (sorivudine) cream 3 percent, oral valaciclovir, and combination topical ARYS-01 cream /oral valaciclovir for treatment of herpes zoster in immunocompetent patients 18 years of age or older

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Oct 2008

At a glance

  • Drugs Sorivudine; Valaciclovir
  • Indications Herpes zoster
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Oct 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 26 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top